Related Experiment Videos
Update on laser subepithelial keratectomy (LASEK).
1Hermann Eye Center, Department of Ophthalmology and Visual Science, University of Texas Health Science Center at Houston, Houston, Texas 77030, USA. richard.w.yee@uth.tmc.edu
Current Opinion in Ophthalmology
|July 3, 2004
Summary
Laser subepithelial keratectomy (LASEK) is a safe and effective refractive surgery. Advances in pharmacology and technology enhance LASEK outcomes, offering superior visual acuity compared to LASIK.
Area of Science:
- Ophthalmology
- Refractive Surgery
- Corneal Surgery
Background:
- Laser subepithelial keratectomy (LASEK) is an established procedure for refractive error correction.
- Comparison with LASIK (laser-assisted in situ keratomileusis) indicates LASEK's continued relevance.
- Technological and pharmacological advancements are refining LASEK applications.
Purpose of the Study:
- To review current concepts and techniques in LASEK.
- To explore the role of pharmacology in LASEK procedures.
- To identify strategies for optimizing LASEK outcomes.
Main Methods:
- Literature review of recent studies on LASEK.
- Analysis of pharmacological and technological interventions.
- Evaluation of outcome data and safety profiles.
Main Results:
- LASEK demonstrates a favorable safety and visual acuity profile compared to LASIK.
- Pharmacological agents and improved algorithms enhance LASEK efficacy.
- Wavefront technology integration with LASEK shows promise for superior refractive results.
Conclusions:
- LASEK provides excellent uncorrected and best-corrected visual acuity.
- Postoperative complications like pain, infection, and haze are manageable with current treatments.
- Combining wavefront technology with LASEK may yield optimal refractive outcomes.